Skip to main content

Table 1 Summary of pulmonary and vascular findings in SIOD patients with SMARCAL1 mutations

From: Reduced elastogenesis: a clue to the arteriosclerosis and emphysematous changes in Schimke immuno-osseous dysplasia?

Pedigree No.

SMARCAL1 mutations

Sex

Pulmonary findings

Vascular findings

Age at death

Cause of death

   

Age at onset

Lung dysfunction or pathology

Age at onset

CVA

TIA

Moya moya

  

SD4a

c.[1930C>T];[410delA]

F

 

NR

 

-

NR

NR

8

Renal failure

SD4b

c.[1930C>T];[410delA]

M

 

NR

 

-

NR

NR

8

Renal failure

SD8

c.[1190delT];[?]A

F

 

NR

 

-

NR

NR

5.7

Pneumonia

SD16

c.[1933C>T];[1643T>A]

M

34

Mild panlobular emphysema with dyspnea, pulmonary hypertension, restrictive lung disease

 

-

-

-

  

SD18a

c.[1756C>T];[1756C>T]

M

 

NR

 

NR

-

NR

43

Cryptococcus meningitis

SD18c

c.[1756C>T];[1756C>T]

F

 

-

 

-

-

-

  

SD22

c.[2459G>A];[2459G>A]

M

 

NR

8

-

+

-

14.6

CMV infection

SD23

c.[2542G>T];[2542G>T]

M

 

NR

4.1

+

+

-

10.3

Unknown

SD24

NT_005403.17: g.[67482574_67497178del] +[67482574_67497178del]

F

 

-

7.5

+

+

NR

9

CVE

SD25

c.[100C>T];[49C>T]

F

 

-

5

+

+

NR

10.1

CVE

SD26

c.[2542G>T];[1190delT]

M

NR

Pulmonary edema

5.3

+

+

-

8

Renal and bone marrow failure

SD27

c.[1940A>C];[1940A>C]

F

 

-

 

-

-

-

25.6

Infectious pulmonary disease

SD28

c.[1696A>T;1698G>C;1702delG]; [1696A>T;1698G>C;1702delG]

M

12

Chronic cough, dyspnea, pulmonary hypertension

 

NR

-

NR

12

Pulmonary hypertension

SD29

c.[1934delG];[862+1G>T]

M

3.7

Pulmonary edema, restrictive lung disease, pulmonary fibrosis

< 3

+

+

NR

4

Infectious pulmonary diseaseB

SD30

c.[1132G>T];[1132G>T]

F

 

NR

5.7

+

-

+

10

HSV pneumonitis

SD31

NT_005403.17: g.[67482574_67497178del] +[67482574_67497178del]

F

 

NR

11

+

+

+

14

Lymphoproliferative disease (secondary)

SD33a

c.[1146_1147delAA;1147+1_2delGT]; [1097-2A>G]

F

 

-

 

-

-

NR

2.8

Bone marrow failure

SD33b

c.[1146_1147delAA;1147+1_2delGT]; [1097-2A>G]

M

 

-

< 1

+

-

NR

3.7

CVE

SD35

c.[1736C>T];[2321C>A]

M

NR

Pulmonary fibrosis

 

-

-

-

8

Renal failure

SD38

c.[1096+1G>A];[1096+1G>A]

M

2

Asthma

NR

NR

+

-

10.8

Complications of blood stem cell transplant

SD39

c.[2114C>T];[1402G>C]

M

 

NR

11

+

+

NR

15

CVE

SD44

c.[2321C>A];[1191delG]

M

 

-

9

+

+

NR

11.9

Digestive bleeding

SD47

c.[2459G>A];[?]A

M

 

-

7

+

+

-

  

SD48

c.[1939A>C];[1939A>C]

F

6.8

Pulmonary hypertension

4

+

+

+

6.8

EBV pneumonia

SD49

c.[2321C>A];[1920_1921insG]

M

4.8

Pulmonary edema

 

-

-

-

4.8

Unknown

SD50

c.[2542G>T];[2542G>T]

F

3

Restrictive lung disease

4.5

+

+

NR

8

Peritonitis and sepsis post transverse colon perforation

SD51

c.[2542G>T];[2459G>A]

F

 

-

 

-

-

-

  

SD53

c.[2291G>A];[2543G>T]

M

 

NR

 

-

-

NR

  

SD57

c.[955C>T];[955C>T]

F

< 10

Asthma, wheezing, basilar atelectasia

8

+

+

-

28

Pancreatitis

SD60

c.[2542G>T];[2542G>T]

M

NR

Pulmonary edema, pulmonary hypertension, emphysematous changes upon autopsy

8

+

+

NR

13.7

CVE

SD61

c.[1146_1147delAA;1147+1_2delGT]; [1146_1147delAA;1147 + 1_2delGT]

M

 

-

 

-

-

NR

5

Lymphoproliferative disease (primary)

SD65a

c.[2542G>T];[836T>C]

M

 

-

 

-

-

-

  

SD65b

c.[2542G>T];[836T>C]

M

23

Diffusion and perfusion lung disorder

14

+

+

-

  

SD66

c.[1933C>T];[1933C>T]

M

NR

Pulmonary edema

7

+

+

+

13

Congestive heart failure

SD68

c.[1940A>C];[2462T>G]

F

 

-

6

+

+

-

7.1

CVE

SD70

c.[340_341insAGTCCAC];[836T>C]

F

 

-

6

+

+

-

18

Recurrent ileus pathology

SD71

c[1000C>T];[836T>C]

M

 

-

6

+

+

-

9

Unknown

SD74

c.[1736C>T];[?]A

M

 

-

 

-

-

-

  

SD78

c.[2264T>G];[1439C>T]

F

 

-

 

NR

-

NR

10

Pneumonia

SD79

c.[2459G>A];[?]A

F

 

-

 

-

-

-

10

Complications of BMT

SD84

c.[2104T>G];[1248_1249insC]

M

NR

Pulmonary hypertension, emphysematous changes upon autopsy

10

-

+

+

23

Pulmonary hypertension with heart failure

SD86

c.[2263_2282delATCGATGGCTCCACCTCATC];[1129G>C]

F

 

-

 

-

-

-

5.7

Complications following BMT

SD96

c.[1427G>A];[1427G>A]

M

6

Recurrent lung infections

 

-

-

-

6

InfectionC

SD99

c.[1402G>C];[1402G>C]

F

5.5

Pulmonary edema

 

-

-

NR

5.5

Pulmonary edema and left heart failure

SD101

c.[2542G>T];[2542G>T]

M

 

NR

3

-

+

-

  

SD102

c.[2542G>T];[2542G>T]

M

 

NR

 

NR

NR

NR

8

Renal failure

SD106

c.[1682G>A];[1682G>A]

M

4

Chronic coughing and wheezing

5.5

-

+

NR

8

Non-Hodgkin Lymphoma

SD107

c.[2542G>T];[2542G>T]

F

3

Restrictive lung disease

 

NR

-

NR

6

Thrombosis

SD108a

c.[1798C>T];[1798C>T]

M

 

-

 

-

-

-

  

SD108b

c.[1798C>T];[1798C>T]

M

 

-

 

-

-

NR

  

SD111

c.[1129G>C];[1592T>C]

M

13

Pulmonary hypertension, chronic cough, restrictive lung disease

15

+

+

-

17.5

Respiratory failure

SD112a

c.[1934G>A];[2542G>T]

F

 

-

 

-

-

-

  

SD112b

c.[1934G>A];[2542G>T]

F

 

-

 

-

-

-

  

SD114

c.[1898T>C];[1898T>C]

M

 

-

4

+

-

+

9.5

Unknown

SD115

c.[1437_1438insG];[1437_1438insG]

F

< 0.6

Mild bronchiectasis

 

-

-

-

1

Pneumonia with respiratory failure

SD119

c.[2449C>T];[2542G>T]

F

 

NR

 

NR

-

NR

  

SD120

c.[2291G>A];[2542G>T]

M

NR

Restrictive lung disease, emphysematous changes

3

-

+

-

5.5

Respiratory failure

SD121

c.[1382G>A];[2542G>T]

F

 

-

3.3

+

-

-

4.8

CVE

SD123

c.[49C>T];[49C>T]

F

 

-

4

-

+

-

  

SD124

c.[1920_1921insG];[1920_1921insG]

M

 

-

 

-

NR

-

  

SD127

c.[1736C>T];[1736C>T]

F

9

Reactive airway disease

7

+

+

+

  

SD131

c.[1026C>A];[2264T>G]

M

 

-

NR

+

-

-

4.6

Cerebral hemorrhage

SD133a

c.[863-2A>G;2343_2347_delGCTGT]; [=;2343_2347_delGCTGT]

F

 

-

 

-

-

-

3

Pulmonary embolism (secondary)

SD133b

c.[863-2A>G;2343_2347_delGCTGT]; [=;2343_2347_delGCTGT]

F

       

Terminated pregnancy

SD138

c.[2542G>T];[2542G>T]

M

 

-

NA

 

NA

NA

NA

 
  1. Abbreviation: +, feature present; -, feature not present; BMT, bone marrow transplant; CVE, cerebrovascular event; CMV, cytomegalovirus; EBV, Epstein-Barr virus; F, female; HSV, herpes simplex virus; M, male; NA, not applicable; NR, not reported; TIA, transient ischemic attack.
  2. A[?] represents alleles with noncoding SMARCAL1 mutations as described by Clewing et al.[60].
  3. BNo bacteriologic or viral proof.
  4. CInfection of peritoneal dialysis fluid.